U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07423286) titled 'A Study to Understand What the Body Does to the Study Medicine Called PF-07248144 When Taken by Healthy Adults' on Nov. 20, 2025.
Brief Summary: For this study, the study medicine has been specially prepared to contain radiolabeled carbon [14C]. [14C] is a naturally occurring radioactive form of the element carbon. Adding a low dose of radiation to the study medicine does not change how the medicine works but helps to see how the medicine appears in the blood, urine, and stool after it is given. This type of study is called a radiolabeled study.
The purpose of this radiolabeled study is to learn how a certain amount of [14C] PF-072...